article · European Journal of Medicinal Chemistry

Rationally designed Pyrazolo[1,5-a]pyrimidines as dual inhibitors of CA IX/XII and CDK6: A novel approach for NSCLC treatment

Mahmoud S Elkotamy
Hazem A. Ghabbour
Alessio Nocentini
Claudiu T. Supuran
Rania S. M. Ismail
Rofaida Salem
Wessam M. El-Refaie
Wagdy M. Eldehna
Mohamed Farès
Abdulrahman A. Almehizia
Simone Giovannuzzi
Islam A Elkelesh
Ahmed M. Naglah
Hatem A. Abdel‐Aziz

20255 citationsPharos University in Alexandria

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Advanced Breast Cancer Therapies
Cancer-related Molecular Pathways
Synthesis of Organic Compounds

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.ejmech.2025.117752

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.